Literature DB >> 7389746

Microbiological transformation of 1,2-diphenyl-3,5 dioxo-4-n-butyl pyrazolidine (phenylbutazone).

J Favero, F Winternitz.   

Abstract

Microbiological conversion of phenylbutazone with Rhizopus arrhizus Fischer gave 4-hydroxy phenylbutazone in excellent yield. Spectral studies, mass spectrometry, in particular, were made of the obtained metabolite; other experiments performed with the intact microorganism or with the cell-free system, as well as studies with the well-known metabolic inhibitor, SKF 525 A, indicated that the obtained 4-hydroxy phenylbutazone was not an artefact. Similar experiments were performed on oxyphenbutazone.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7389746     DOI: 10.1007/BF03189436

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  14 in total

1.  Microbial models of mammalian metabolism.

Authors:  R V Smith; J P Rosazza
Journal:  J Pharm Sci       Date:  1975-11       Impact factor: 3.534

2.  Inhibitory effects of beta-diethylaminoethyl diphenylpropylacetate on a variety of drug metabolic pathways in vitro.

Authors:  J R COOPER; J AXELROD; B B BRODIE
Journal:  J Pharmacol Exp Ther       Date:  1954-09       Impact factor: 4.030

3.  Mechanism of the potentiating action of beta-diethylaminoethyl diphenylpropylacetate.

Authors:  J AXELROD; J REICHENTHAL; B B BRODIE
Journal:  J Pharmacol Exp Ther       Date:  1954-09       Impact factor: 4.030

4.  Oxidation of oxyphenbutazone by sheep vesicular gland microsomes and lipoxygenase.

Authors:  P S Portoghese; K Svanborg; B Samuelsson
Journal:  Biochem Biophys Res Commun       Date:  1975-04-07       Impact factor: 3.575

5.  [Mass spectrometric study on 3,5-dioxo-pyrazolidines and their methylation products].

Authors:  B Unterhalt
Journal:  Arch Pharm (Weinheim)       Date:  1972-05       Impact factor: 3.751

6.  Hydroxylation of Reichstein's compound S with cell-free preparations from Curvularia lunata.

Authors:  M H Zuidweg
Journal:  Biochim Biophys Acta       Date:  1968-01-10

7.  [Chemical characteristic of degradation products of drugs. IV. Mechanism of degradation of phenylbutazone in pharmaceutical preparations].

Authors:  E Pawelczyk; R Wachowiak
Journal:  Acta Pol Pharm       Date:  1969       Impact factor: 0.330

8.  Microbial models of mammalian metabolism. Aromatic hydroxylation.

Authors:  R V Smith; J P Rosazza
Journal:  Arch Biochem Biophys       Date:  1974-04-02       Impact factor: 4.013

9.  The metabolic fate of phenylbutazone (butazolidin) in man.

Authors:  J J BURNS; R K ROSE; S GOODWIN; J REICHENTHAL; E C HORNING; B B BRODIE
Journal:  J Pharmacol Exp Ther       Date:  1955-04       Impact factor: 4.030

10.  Metabolism of phenylbutazone in man.

Authors:  W Dieterle; J W Faigle; F Früh; H Mory; W Theoblad; K O Alt; W J Richter
Journal:  Arzneimittelforschung       Date:  1976-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.